Thomas Mandl
21 – 30 of 77
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies
(
- Contribution to journal › Article
-
Mark
Autoimmune congenital heart block and primary Sjögren's syndrome : characterisation and outcomes of 49 cases
(
- Contribution to journal › Article
-
Mark
Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies
(
- Contribution to journal › Article
-
Mark
Cigarette smoking patterns preceding primary Sjögren’s syndrome
(
- Contribution to journal › Article
- 2019
-
Mark
Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjögren's syndrome
(
- Contribution to journal › Article
-
Mark
Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjögren's syndrome
(
- Contribution to journal › Article
-
Mark
Infections increase the risk of developing Sjögren's syndrome
(
- Contribution to journal › Article
-
Mark
Increased B-cell activating factor, interleukin-6, and interleukin-8 in induced sputum from primary Sjögren's syndrome patients
(
- Contribution to journal › Article
-
Mark
Efficacy and safety of topical and systemic medications : A systematic literature review informing the EULAR recommendations for the management of Sjögren's syndrome
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren’s syndrome without disease modifying treatment
(
- Contribution to journal › Article